Product image of Modafinil Emona (Modafinil) supplied by GNH India

Modafinil Emona

Active Ingredient:
Modafinil
Origin:
EU

Modafinil Emona (Modafinil)

Modafinil, the active ingredient in Modafinil Emona, is a eugeroic (wakefulness‑promoting agent) presented as an oral tablet for oral use. It treats excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder.\n\nGNH India supplies Modafinil Emona as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Emona Biopharma D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Modafinil is a wakefulness‑promoting agent indicated for several sleep‑related disorders.\n\n- Narcolepsy: reduces daytime sleepiness and improves alertness.\n- Obstructive sleep apnea (excessive daytime sleepiness): helps maintain wakefulness in patients with residual sleepiness despite standard therapy.\n- Shift work sleep disorder: decreases sleepiness during scheduled work periods, supporting better performance.

How It Works

  • Modafinil promotes wakefulness primarily by inhibiting the reuptake of dopamine, thereby increasing extracellular dopamine concentrations in key brain regions. It also modulates orexinergic pathways and influences other neurotransmitters such as norepinephrine and histamine, contributing to enhanced alertness. The precise mechanism is not fully elucidated, but the combined actions support sustained wakefulness without the typical stimulant profile.

Side Effects

  • Modafinil may cause a range of adverse reactions, from mild to serious.\n\nCommon Side Effects:\n- Headache\n- Nausea\n- Insomnia\n- Anxiety or nervousness\n- Dizziness\n- Dry mouth\n\nSerious or Rare Side Effects:\n- Severe skin reactions (e.g., Stevens‑Johnson syndrome)\n- Psychiatric disturbances (e.g., hallucinations, mania)\n- Cardiovascular events (e.g., hypertension, arrhythmia)\n- Allergic reactions (e.g., anaphylaxis)\n- Liver injury\n- Suicidal thoughts or behavior

Precautions & Warnings

  • Before prescribing Modafinil, clinicians should consider several safety factors.\n\n- Medical evaluation: assess cardiovascular status and history of cardiac disease.\n- Drug interactions: review concomitant medications that affect CYP3A4 metabolism.\n- Pregnancy and lactation: avoid use unless benefits clearly outweigh potential risks.\n- Psychiatric history: monitor for mood changes, psychosis, or suicidal ideation.\n- Renal/hepatic impairment: dose adjustment may be required based on organ function.\n- Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

  • Modafinil can interact with several drug classes, requiring careful management.\n\nMajor Interactions (Avoid):\n- CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase plasma concentrations and risk of toxicity.\n- Central nervous system depressants (e.g., benzodiazepines, alcohol): may diminish wake‑promoting effects.\n- Monoamine oxidase inhibitors: risk of hypertensive crisis when combined.\n\nModerate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce efficacy by lowering drug levels.\n- Oral contraceptives: may decrease hormonal effectiveness, requiring additional contraception.\n- Antihypertensive agents: may enhance blood‑pressure‑lowering effects, necessitating monitoring.

Frequently Asked Questions

Modafinil Emona is prescribed to improve wakefulness in patients who experience excessive daytime sleepiness due to narcolepsy, obstructive sleep apnea, or shift work sleep disorder. By reducing sleepiness, it helps individuals maintain alertness and functional performance during daily activities.

Modafinil works mainly by blocking the reuptake of dopamine, which raises dopamine levels in the brain and promotes alertness. It also influences orexin, norepinephrine, and histamine pathways, contributing to a sustained wakeful state without the classic stimulant effects of other agents.

The appropriate dose of Modafinil Emona is determined by the prescribing clinician based on the patient’s condition, response, and any comorbidities. Healthcare professionals tailor the regimen to achieve optimal wakefulness while minimizing potential adverse effects.

Safety data for Modafinil during pregnancy and lactation are limited, and the drug is generally not recommended for use in these populations unless the potential benefit justifies the possible risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Modafinil Emona, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with traditional stimulants such as amphetamines, Modafinil has a lower risk of cardiovascular stimulation and abuse potential. Its mechanism focuses on dopamine reuptake inhibition and orexin modulation, offering wakefulness with fewer typical stimulant side effects, though individual response can vary.

Modafinil Emona should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and avoid exposing it to direct sunlight.

Modafinil Emona is taken orally, usually with a glass of water. It is generally recommended to take the dose in the morning to avoid interference with nighttime sleep, but the exact timing should follow the prescriber’s instructions.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, psychiatric events like hallucinations or mania, cardiovascular complications (e.g., hypertension, arrhythmias), liver injury, and rare but critical allergic reactions. Patients should seek immediate medical attention if any of these occur.

Modafinil Emona is contraindicated in individuals with known hypersensitivity to modafinil or any of its excipients, those with a history of severe cardiovascular disease, and patients currently taking monoamine oxidase inhibitors. Caution is also advised for persons with uncontrolled psychiatric disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Modafinil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT